Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Aerts

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2009
Carbohydrate antigen 19-9 is extremely elevated in polycystic liver diseaseEsmé Waanders, Loes van Keimpema, Johannes T Brouwer, et al.
The Journal of Pathology|September 15, 2005
Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liverSara Vander Borght, Louis Libbrecht, Hans Blokzijl, et al.
Hepatology (Baltimore, Md.)|January 25, 2012
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypesMina Komuta, Olivier Govaere, Vincent Vandecaveye, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 4, 2006
Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trialDavid Cassiman, Mieke Roelants, Gerda Vandenplas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 6, 2002
Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literaturePatrick Itterbeek, Peter Vandenberghe, Frederik Nevens, et al.
Hepatology (Baltimore, Md.)|April 9, 2008
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell originMina Komuta, Bart Spee, Sara Vander Borght, et al.
Journal of Hypertension|December 5, 2006
-391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studiesKathleen Freson, Katarzyna Stolarz, Raymond Aerts, et al.
Journal of Gastroenterology and Hepatology|September 18, 2007
Congenital veno-venous malformations of the liver: widely variable clinical presentationsPeter Witters, Geert Maleux, Christophe George, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Combined 'en bloc' liver and pancreas transplantation in patients with liver disease and type 1 diabetes mellitusJacques Pirenne, Koen Deloose, Willy Coosemans, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2015
Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survivalGeert Maleux, Christophe Deroose, Annouschka Laenen, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2009
Carbohydrate antigen 19-9 is extremely elevated in polycystic liver diseaseEsmé Waanders, Loes van Keimpema, Johannes T Brouwer, et al.
The Journal of Pathology|September 15, 2005
Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liverSara Vander Borght, Louis Libbrecht, Hans Blokzijl, et al.
Hepatology (Baltimore, Md.)|January 25, 2012
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypesMina Komuta, Olivier Govaere, Vincent Vandecaveye, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 4, 2006
Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trialDavid Cassiman, Mieke Roelants, Gerda Vandenplas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 6, 2002
Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literaturePatrick Itterbeek, Peter Vandenberghe, Frederik Nevens, et al.
Hepatology (Baltimore, Md.)|April 9, 2008
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell originMina Komuta, Bart Spee, Sara Vander Borght, et al.
Journal of Hypertension|December 5, 2006
-391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studiesKathleen Freson, Katarzyna Stolarz, Raymond Aerts, et al.
Journal of Gastroenterology and Hepatology|September 18, 2007
Congenital veno-venous malformations of the liver: widely variable clinical presentationsPeter Witters, Geert Maleux, Christophe George, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Combined 'en bloc' liver and pancreas transplantation in patients with liver disease and type 1 diabetes mellitusJacques Pirenne, Koen Deloose, Willy Coosemans, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2015
Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survivalGeert Maleux, Christophe Deroose, Annouschka Laenen, et al.
Pageof 5